Download presentation
Presentation is loading. Please wait.
Published byReynold Todd Modified over 5 years ago
1
Results of the VALOR II trial of the Medtronic Valiant Thoracic Stent Graft
Mark F. Conrad, MD, MMSc, James Tuchek, MD, Robert Freezor, MD, Joseph Bavaria, MD, Rodney White, MD, Ronald Fairman, MD Journal of Vascular Surgery Volume 66, Issue 2, Pages (August 2017) DOI: /j.jvs Copyright © 2017 The Authors Terms and Conditions
2
Fig 1 Kaplan-Meier estimate for freedom from all-cause mortality over 5 years of the VALOR II (Evaluation of the Clinical Performance of the Valiant Thoracic Stent Graft System in the Treatment of Descending Thoracic Aneurysms of Degenerative Etiology in Subjects Who Are Candidates for Endovascular Repair) trial. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2017 The Authors Terms and Conditions
3
Fig 2 Kaplan-Meier estimate for freedom from aneurysm-related mortality over 5 years of the VALOR II (Evaluation of the Clinical Performance of the Valiant Thoracic Stent Graft System in the Treatment of Descending Thoracic Aneurysms of Degenerative Etiology in Subjects Who Are Candidates for Endovascular Repair) trial. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2017 The Authors Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.